Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +46.08%
#3 Glidr Glidr +35.94%
#4 Cysic Cysic +32.50%
#5 Walrus Walrus +23.65%
#6 Tutorial Tutorial +23.18%
#7 Enso Enso +18.12%
#8 Humanity Humanity +18.02%
#9 Codatta Codatta +14.33%
#10 Huma Finance Huma Finance +13.74%
Coin of the day
EXOD EXOD
Setări
Limbă
ROMâNă
Monedă
USD
Temă
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Rang în acțiuni #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Preț acțiune
$0.6
Ultima sincronizare: 2024-08-14
Capitalizare de piață
$2.09M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
SG
Tranzacționează ASLAN Pharmaceuticals Limited (ASLN)

Categorie

Healthcare
Câștiguri pentru ASLAN Pharmaceuticals Limited (ASLN)
Câștiguri în Mar 2024 TTM: $-34.90M
Conform celor mai recente rapoarte financiare ale ASLAN Pharmaceuticals Limited, câștigurile actuale ale companiei sunt $-34.90M. În anul 2022, compania a înregistrat un câștig de $-51.28M, o scădere comparativ cu câștigului din 2021, care a fost de $-31.59M. Câștigurile afișate pe această pagină sunt cele înainte de dobânzi și impozite, cunoscute și ca EBIT.
Istoricul câștigurilor pentru ASLAN Pharmaceuticals Limited din 2014 până în 2026
Câștiguri la sfârșitul fiecărui an
An Câștiguri Schimbă
2026 (TTM) $-34.90M -20.84%
2023 $-44.09M -14.03%
2022 $-51.28M 62.34%
2021 $-31.59M 86.14%
2020 $-16.97M -63.63%
2019 $-46.66M 10.64%
2018 $-42.17M 3.58%
2017 $-40.71M 352.17%
2016 $-9.00M -32.43%
2015 $-13.33M 80.95%
2014 $-7.36M 0.00%
Câștiguri pentru companii similare sau concurente
Companie Câștiguri Diferență de câștiguri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -15,214.03%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -5,689.14%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -8,712.20%
BE